跳至主要内容
临床试验/NCT06045013
NCT06045013招募中3 期

Comparison of the Efficacy Between Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone Injection in Patients With Carpal Tunnel Syndrome: a Prospective, Randomized Double-blind Clinical Trial.

General and Veteran Hospital Croatian Pride Knin1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年9月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
70
试验地点
1
主要终点
Pain intensity at 4 weeks post injection

研究概览

简要总结

The goal of this prospective, randomized, double-blinded, head-to-head comparative study is to compare the efficacy of ultrasound-guided 4 ml 5% dextrose perineural injection versus 3 ml 5% dextrose with 1 ml 40 mg/ml methylprednisolone perineural injection in patients with carpal tunnel syndrome (CTS).

The main questions it aims to answer are:

Is there a difference in efficacy between interventions regarding 1. pain alleviation, 2. improvement in symptoms severity and functional status, 3. improvement in grip strength, 4. size of median nerve cross-sectional area, and 5. improvement in quality of life during the six-month post-intervention follow-up period?

详细描述

The research will be conducted in the General and Veteran Hospital "Croatian Pride" Knin.

The research will be a prospective, randomized, double-blinded, head-to-head comparative study.

The goal of the research is to compare the efficacy of ultrasound-guided 5% dextrose injection versus 5% dextrose with 40 mg methylprednisolone injection in patients with carpal tunnel syndrome (CTS).

Randomization of patients will be performed before the intervention using computer software.

All participants will sign written informed consent and the study will be performed under the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study is approved by the Ethical Committee at the General and Veteran Hospital "Croatian Pride" Knin (approval number: 510.01/23-01/79).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18 and 80 years,
  • the diagnosis of idiopathic CTS.

排除标准

  • contraindications for local application of methylprednisolone or 5% dextrose (hypersensitivity to the drug, infection and skin damage at the application site),
  • previous wrist surgery,
  • traumatic wrist injury within 2 years,
  • previous wrist injection within 6 months,
  • previous physical therapy within 6 months,
  • history of peripheral traumatic nerve injury in the upper extremity, brachial plexopathy, severe cervical radiculopathy, and thoracic outlet syndrome,
  • history of diabetes
  • history of thyroid disease,
  • history of inflammatory rheumatic disease,
  • pregnancy,
  • inability to cooperate with the study protocol.

研究组 & 干预措施

5% dextrose injection

Active Comparator

Ultrasound-guided 4 ml single injection of 5% dextrose

干预措施: 5% dextrose injection (Drug)

5% dextrose injections with methylprednisolone acetate

Active Comparator

Ultrasound-guided single injection of 3 ml 5% dextrose plus 1 ml 40 mg/ml methylprednisolone acetate

干预措施: 5% dextrose injections with methylprednisolone acetate 40 mg/ml (Drug)

结局指标

主要结局

Pain intensity at 4 weeks post injection

时间窗: before injection, 4 weeks post injection

Assessment of pain intensity using 10 cm Visual Analogue Scale (VAS pain), 0-10; 0=no pain, 10=the most severe pain.

次要结局

  • Grip strength(before injection, 4, 12 and 24 weeks post injection.)
  • Pain intensity at 12 and 24 weeks post injection(before injection,12 and 24 weeks post injection.)
  • Symptoms severity and functional impairment of carpal tunnel syndrome (CTS)(before injection, 4, 12 and 24 weeks post injection.)
  • Median nerve cross-sectional area (CSA)(before injection, 4, 12 and 24 weeks post injection.)
  • Quality of life (QoL)(before injection, 4, 12 and 24 weeks post injection.)

研究者

发起方
General and Veteran Hospital Croatian Pride Knin
申办方类型
Other
责任方
Principal Investigator
主要研究者

Igor Begović

Physical medicine and rehabilitation specialist

General and Veteran Hospital Croatian Pride Knin

研究点 (1)

Loading locations...

相似试验